These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30488021)

  • 61. Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma.
    Nouri YM; Kim JH; Yoon HK; Ko HK; Shin JH; Gwon DI
    Korean J Radiol; 2019 Jan; 20(1):34-49. PubMed ID: 30627020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcatheter embolization therapy in liver cancer: an update of clinical evidences.
    Wáng YX; De Baere T; Idée JM; Ballet S
    Chin J Cancer Res; 2015 Apr; 27(2):96-121. PubMed ID: 25937772
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry.
    Brown RE; Gibler KM; Metzger T; Trofimov I; Krebs H; Romero FD; Scoggins CR; McMasters KM; Martin RC
    Am Surg; 2011 Jan; 77(1):93-8. PubMed ID: 21396314
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
    Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
    Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
    Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
    [No Abstract]   [Full Text] [Related]  

  • 69. Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment.
    Dubbelboer IR; Sjögren E; Lennernäs H
    AAPS J; 2018 Aug; 20(6):96. PubMed ID: 30167825
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation Study.
    Pauwels X; Azahaf M; Lassailly G; Sergent G; Buob D; Truant S; Boleslawski E; Louvet A; Gnemmi V; Canva V; Mathurin P; Pruvot FR; Leteurtre E; Ernst O; Dharancy S
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):685-92. PubMed ID: 25342136
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conventional versus Doxorubicin-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: a Tertiary Medical Centre Experience in Malaysia.
    Rahman FA; Naidu J; Ngiu CS; Yaakob Y; Mohamed Z; Othman H; Jarmin R; Elias MH; Hamid NA; Mokhtar NM; Ali RR
    Asian Pac J Cancer Prev; 2016; 17(8):4037-41. PubMed ID: 27644658
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma.
    Cucchetti A; Trevisani F; Cappelli A; Mosconi C; Renzulli M; Pinna AD; Golfieri R
    Dig Liver Dis; 2016 Jul; 48(7):798-805. PubMed ID: 27263056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry.
    Martin RC; Rustein L; Pérez Enguix D; Palmero J; Carvalheiro V; Urbano J; Valdata A; Kralj I; Bosnjakovic P; Tatum C
    J Am Coll Surg; 2011 Oct; 213(4):493-500. PubMed ID: 21856182
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
    Nishikawa H; Kita R; Kimura T; Osaki Y
    Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.
    Negussie AH; Dreher MR; Johnson CG; Tang Y; Lewis AL; Storm G; Sharma KV; Wood BJ
    J Mater Sci Mater Med; 2015 Jun; 26(6):198. PubMed ID: 26105830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
    Ludwig JM; Zhang D; Xing M; Kim HS
    Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spontaneous liver rupture after treatment with drug-eluting beads.
    Ritter CO; Wartenberg M; Mottok A; Steger U; Goltz JP; Hahn D; Kickuth R
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):198-202. PubMed ID: 21431968
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients.
    Facciorusso A; Licinio R; Muscatiello N; Di Leo A; Barone M
    World J Hepatol; 2015 Aug; 7(16):2009-19. PubMed ID: 26261690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre.
    Molinari M; Kachura JR; Dixon E; Rajan DK; Hayeems EB; Asch MR; Benjamin MS; Sherman M; Gallinger S; Burnett B; Feld R; Chen E; Greig PD; Grant DR; Knox JJ
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):684-92. PubMed ID: 17100154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.